Surufatinib combined with photodynamic therapy induces ferroptosis to inhibit cholangiocarcinoma in vitro and in tumor models

• Main Authors: Yun-Peng Huang (Author), Yong-Xiang Wang (Author), Hui Zhou (Author), Zhong-Tao Liu (Author), Zi-Jian Zhang (Author), Li Xiong (Author), Heng Zou (Author), Yu Wen (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The curative effect of single therapy for advanced cholangiocarcinoma (CCA) is poor, thus investigating combined treatment strategies holds promise for improving prognosis. Surufatinib (SUR) is a novel multikinase inhibitor that has been confirmed to prolong survival of patients with advanced CCA. P...